Hepatic arterial infusion but not systemic application of cetuximab in combination with oxaliplatin significantly reduces growth of CC531 colorectal rat liver metastases

PURPOSE: Systemic chemotherapy still represents the gold standard in the treatment of irresectable colorectal liver metastases. Modern anticancer agents like the monoclonal antibody cetuximab have improved the outcome of patients in clinical studies. As hepatic arterial infusion (HAI) is capable to...

Descripción completa

Detalles Bibliográficos
Autores principales: Sperling, Jens, Schäfer, Thilo, Benz-Weißer, Anna, Ziemann, Christian, Scheuer, Claudia, Kollmar, Otto, Schilling, Martin K., Menger, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639362/
https://www.ncbi.nlm.nih.gov/pubmed/23242249
http://dx.doi.org/10.1007/s00384-012-1617-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639362/
https://www.ncbi.nlm.nih.gov/pubmed/23242249
http://dx.doi.org/10.1007/s00384-012-1617-1

Ejemplares similares